Global PROTAC Technology 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07245844

Publication Date:

July 11, 2024

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global PROTAC Technology market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧ROTAC Technology Industry Forecast鈥� looks at past sales and reviews total world PROTAC Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected PROTAC Technology sales for 2023 through 2029. With PROTAC Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PROTAC Technology industry.
This Insight Report provides a comprehensive analysis of the global PROTAC Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PROTAC Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global PROTAC Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PROTAC Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PROTAC Technology.
As a new type of small molecule drug development technology, PROTAC is receiving more and more attention. Major pharmaceutical companies and biotechnology companies have invested heavily in research and development in the hope of making breakthroughs in this field. With the continuous advancement of technology and the accumulation of clinical data, PROTAC is expected to achieve more breakthroughs in the next few years and provide more possibilities for the development of new drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of PROTAC Technology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Based on CRBN
Based on VHL
Segmentation by Application:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Pancreatic Cancer
Lymphoma
Androgenic Alopecia
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Based on CRBN
Based on VHL
Segmentation by Application:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Pancreatic Cancer
Lymphoma
Androgenic Alopecia
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Arvinas
Captor therapeutics
Pfizer
Amgen
Oerth Bio
Bayer
Kymera
Nurix
C4 Therapeutics, Inc.
Astellas Pharma Inc.
AbbVie
Kaituo Pharmaceutical
Betta Pharmaceuticals
Hengrui Medicine
BeiGene
Haichuang Pharmaceutical
East China Pharmaceutical Group

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global PROTAC Technology 麻豆原创 Size 2019-2030
2.1.2 PROTAC Technology 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for PROTAC Technology by Country/Region, 2019, 2023 & 2030
2.2 PROTAC Technology Segment by Type
2.2.1 Based on CRBN
2.2.2 Based on VHL
2.3 PROTAC Technology 麻豆原创 Size by Type
2.3.1 PROTAC Technology 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global PROTAC Technology 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 PROTAC Technology Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Colorectal Cancer
2.4.4 Pancreatic Cancer
2.4.5 Lymphoma
2.4.6 Androgenic Alopecia
2.4.7 Others
2.5 PROTAC Technology 麻豆原创 Size by Application
2.5.1 PROTAC Technology 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global PROTAC Technology 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 PROTAC Technology 麻豆原创 Size by Player
3.1 PROTAC Technology 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global PROTAC Technology Revenue by Player (2019-2024)
3.1.2 Global PROTAC Technology Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global PROTAC Technology Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROTAC Technology by Region
4.1 PROTAC Technology 麻豆原创 Size by Region (2019-2024)
4.2 Global PROTAC Technology Annual Revenue by Country/Region (2019-2024)
4.3 Americas PROTAC Technology 麻豆原创 Size Growth (2019-2024)
4.4 APAC PROTAC Technology 麻豆原创 Size Growth (2019-2024)
4.5 Europe PROTAC Technology 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa PROTAC Technology 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas PROTAC Technology 麻豆原创 Size by Country (2019-2024)
5.2 Americas PROTAC Technology 麻豆原创 Size by Type (2019-2024)
5.3 Americas PROTAC Technology 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PROTAC Technology 麻豆原创 Size by Region (2019-2024)
6.2 APAC PROTAC Technology 麻豆原创 Size by Type (2019-2024)
6.3 APAC PROTAC Technology 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe PROTAC Technology 麻豆原创 Size by Country (2019-2024)
7.2 Europe PROTAC Technology 麻豆原创 Size by Type (2019-2024)
7.3 Europe PROTAC Technology 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa PROTAC Technology by Region (2019-2024)
8.2 Middle East & Africa PROTAC Technology 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa PROTAC Technology 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global PROTAC Technology 麻豆原创 Forecast
10.1 Global PROTAC Technology Forecast by Region (2025-2030)
10.1.1 Global PROTAC Technology Forecast by Region (2025-2030)
10.1.2 Americas PROTAC Technology Forecast
10.1.3 APAC PROTAC Technology Forecast
10.1.4 Europe PROTAC Technology Forecast
10.1.5 Middle East & Africa PROTAC Technology Forecast
10.2 Americas PROTAC Technology Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 PROTAC Technology Forecast
10.2.2 Canada 麻豆原创 PROTAC Technology Forecast
10.2.3 Mexico 麻豆原创 PROTAC Technology Forecast
10.2.4 Brazil 麻豆原创 PROTAC Technology Forecast
10.3 APAC PROTAC Technology Forecast by Region (2025-2030)
10.3.1 China PROTAC Technology 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 PROTAC Technology Forecast
10.3.3 Korea 麻豆原创 PROTAC Technology Forecast
10.3.4 Southeast Asia 麻豆原创 PROTAC Technology Forecast
10.3.5 India 麻豆原创 PROTAC Technology Forecast
10.3.6 Australia 麻豆原创 PROTAC Technology Forecast
10.4 Europe PROTAC Technology Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 PROTAC Technology Forecast
10.4.2 France 麻豆原创 PROTAC Technology Forecast
10.4.3 UK 麻豆原创 PROTAC Technology Forecast
10.4.4 Italy 麻豆原创 PROTAC Technology Forecast
10.4.5 Russia 麻豆原创 PROTAC Technology Forecast
10.5 Middle East & Africa PROTAC Technology Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 PROTAC Technology Forecast
10.5.2 South Africa 麻豆原创 PROTAC Technology Forecast
10.5.3 Israel 麻豆原创 PROTAC Technology Forecast
10.5.4 Turkey 麻豆原创 PROTAC Technology Forecast
10.6 Global PROTAC Technology Forecast by Type (2025-2030)
10.7 Global PROTAC Technology Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 PROTAC Technology Forecast
11 Key Players Analysis
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas PROTAC Technology Product Offered
11.1.3 Arvinas PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Captor therapeutics
11.2.1 Captor therapeutics Company Information
11.2.2 Captor therapeutics PROTAC Technology Product Offered
11.2.3 Captor therapeutics PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Captor therapeutics Main Business Overview
11.2.5 Captor therapeutics Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer PROTAC Technology Product Offered
11.3.3 Pfizer PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen PROTAC Technology Product Offered
11.4.3 Amgen PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 Oerth Bio
11.5.1 Oerth Bio Company Information
11.5.2 Oerth Bio PROTAC Technology Product Offered
11.5.3 Oerth Bio PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Oerth Bio Main Business Overview
11.5.5 Oerth Bio Latest Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer PROTAC Technology Product Offered
11.6.3 Bayer PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Bayer Main Business Overview
11.6.5 Bayer Latest Developments
11.7 Kymera
11.7.1 Kymera Company Information
11.7.2 Kymera PROTAC Technology Product Offered
11.7.3 Kymera PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Kymera Main Business Overview
11.7.5 Kymera Latest Developments
11.8 Nurix
11.8.1 Nurix Company Information
11.8.2 Nurix PROTAC Technology Product Offered
11.8.3 Nurix PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Nurix Main Business Overview
11.8.5 Nurix Latest Developments
11.9 C4 Therapeutics, Inc.
11.9.1 C4 Therapeutics, Inc. Company Information
11.9.2 C4 Therapeutics, Inc. PROTAC Technology Product Offered
11.9.3 C4 Therapeutics, Inc. PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 C4 Therapeutics, Inc. Main Business Overview
11.9.5 C4 Therapeutics, Inc. Latest Developments
11.10 Astellas Pharma Inc.
11.10.1 Astellas Pharma Inc. Company Information
11.10.2 Astellas Pharma Inc. PROTAC Technology Product Offered
11.10.3 Astellas Pharma Inc. PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Astellas Pharma Inc. Main Business Overview
11.10.5 Astellas Pharma Inc. Latest Developments
11.11 AbbVie
11.11.1 AbbVie Company Information
11.11.2 AbbVie PROTAC Technology Product Offered
11.11.3 AbbVie PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 AbbVie Main Business Overview
11.11.5 AbbVie Latest Developments
11.12 Kaituo Pharmaceutical
11.12.1 Kaituo Pharmaceutical Company Information
11.12.2 Kaituo Pharmaceutical PROTAC Technology Product Offered
11.12.3 Kaituo Pharmaceutical PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Kaituo Pharmaceutical Main Business Overview
11.12.5 Kaituo Pharmaceutical Latest Developments
11.13 Betta Pharmaceuticals
11.13.1 Betta Pharmaceuticals Company Information
11.13.2 Betta Pharmaceuticals PROTAC Technology Product Offered
11.13.3 Betta Pharmaceuticals PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Betta Pharmaceuticals Main Business Overview
11.13.5 Betta Pharmaceuticals Latest Developments
11.14 Hengrui Medicine
11.14.1 Hengrui Medicine Company Information
11.14.2 Hengrui Medicine PROTAC Technology Product Offered
11.14.3 Hengrui Medicine PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Hengrui Medicine Main Business Overview
11.14.5 Hengrui Medicine Latest Developments
11.15 BeiGene
11.15.1 BeiGene Company Information
11.15.2 BeiGene PROTAC Technology Product Offered
11.15.3 BeiGene PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 BeiGene Main Business Overview
11.15.5 BeiGene Latest Developments
11.16 Haichuang Pharmaceutical
11.16.1 Haichuang Pharmaceutical Company Information
11.16.2 Haichuang Pharmaceutical PROTAC Technology Product Offered
11.16.3 Haichuang Pharmaceutical PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Haichuang Pharmaceutical Main Business Overview
11.16.5 Haichuang Pharmaceutical Latest Developments
11.17 East China Pharmaceutical Group
11.17.1 East China Pharmaceutical Group Company Information
11.17.2 East China Pharmaceutical Group PROTAC Technology Product Offered
11.17.3 East China Pharmaceutical Group PROTAC Technology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 East China Pharmaceutical Group Main Business Overview
11.17.5 East China Pharmaceutical Group Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.